Abstract:Background: Aging is associated with insulin resistance (IR) and also predisposes to worsening heart failure. We sought to determine if IR in the absence of hyperglycemia predisposed to an accelerated course of LV dysfunction following rapid pacing (RVP) in old dogs with documented IR. Methods: Nine young (Y: 4years) and 7 old (O: 11 years) dogs were instrumented with LV pressure gauges (LVP, LVEDP, LVdP/dt), aortic (systolic and diastolic pressure) and coronary sinus catheters, and flow probes on left circumflex (CBF). Dogs underwent measurements of hemodynamics and plasma substrates and a two- hour hyperinsulinemic-euglycemic clamp to measure WB and myocardial glucose uptake (MGU) at Baseline. Dogs then underwent RVP (240 min-1) until symptomatic DCM developed. Results: At baseline, there was no difference in body weight (Y: 15 ± 0.6; O: 15 ± 0.4 kg) or plasma glucose (Y: 92 ± 4; O: 95 ± 4 mg/dl) but O had higher (p < 0.02) NEFA (Y: 389 ± 45; O: 796 ± 77 mmol/L); and plasma insulin (Y: 38 ± 6; O: 119 ± 20 pmol/L). Old dogs had impaired WB glucose disposition (Y: 11.5 ± 1; O: 8.0 ± 0.5 mg/kg/min, p < 0.05). While basal MGU was not different (Y: 0.38 ± 0.1; O: 0.34 ± 0.08 mg/min), insulin stimulated MGU was depressed in old dogs (Y: 2.5 ± 0.5; O: 1.4 ± 0.4 mg/min, p < 0.05) consistent with both WB and myocardial IR. Myocardial mitochondria show vaculozation and disruption in old compared to young dogs. Old dogs developed severe symptomatic DCM within 7 days, while severe DCM took 28 days in young dogs (see table). Conclusion: Aging is associated with WB and myocardial IR that predisposes to accelerated course of DCM following RVP in conscious dogs. IR may explain the predisposition of older patients to DCM even in the absence of hyperglycemia. Tabled 1 Young (n = 9) Old (n = 7) Baseline DCM Baseline DCM Pacing (days) 28 ± 2 7 ± 3 † p < 0.01 Y vs. O. LVP (mmHg) 118 ± 6 101 ± 4 ∗ p < 0.05 compared to baseline. 130 ± 3 † p < 0.01 Y vs. O. 108 ± 3 ∗ p < 0.05 compared to baseline. LVEDP (mmHg) 9 ± 1 30 ± 2 ∗ p < 0.05 compared to baseline. 13 ± 2 29 ± 2 ∗ p < 0.05 compared to baseline. LVdP/dt (mmHg/sec) 2890 ± 165 1416 ± 118 ∗ p < 0.05 compared to baseline. 2792 ± 212 1363 ± 132 ∗ p < 0.05 compared to baseline. HR (min¯1) 86 ± 4 112 ± 5 ∗ p < 0.05 compared to baseline. 95 ± 8 114 ± 9 ∗ p < 0.05 compared to baseline. MAP (mmHg) 90 ± 3 83 ± 3 ∗ p < 0.05 compared to baseline. 104 ± 4 † p < 0.01 Y vs. O. 85 ± 2 ∗ p < 0.05 compared to baseline. LVEDD (mm) 38 ± 2 44 ± 2 ∗ p < 0.05 compared to baseline. 40 ± 1 44 ± 3 ∗ p < 0.05 compared to baseline. † p < 0.01 Y vs. O. Open table in a new tab

GLP-1 (7–36) Amide Restores Myocardial Insulin Sensitivity and Prevents the Progression of Heart Failure in Senescent Beagles

Active Metabolite of Glp-1 Mediates Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs with Dilated Cardiomyopathy

Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs with Pacing-Induced Dilated Cardiomyopathy

GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and mice

Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake Via P38 Alpha Map Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs with Dilated Cardiomyopathy

Aging is Associated with Myocardial Insulin Resistance and Mitochondrial Dysfunction.

Improvement of Cardiac and Systemic Function in Old Mice by Agonist of Growth Hormone‐releasing Hormone

Cardiac Molecular Analysis Reveals Aging-Associated Metabolic Alterations Promoting Glycosaminoglycans Accumulation via Hexosamine Biosynthetic Pathway

Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice

Cardiac-specific Overexpression of Insulin-Like Growth Factor 1 Attenuates Aging-Associated Cardiac Diastolic Contractile Dysfunction and Protein Damage.

Isthmin-1 Improves Aging-Related Cardiac Dysfunction in Mice through Enhancing Glycolysis and SIRT1 Deacetylase Activity

Enhanced Cardiomyocyte NLRP3 Inflammasome-Mediated Pyroptosis Promotes d-Galactose-Induced Cardiac Aging

Older Dogs with Whole Body and Myocardial Insulin Resistance Develop an Accelerated Course of Dilated Cardiomyopathy Following Rapid Pacing

Paracrine IGF-1 Activates SOD2 Expression and Regulates ROS/p53 Axis in the Treatment of Cardiac Damage in D-Galactose-Induced Aging Rats after Receiving Mesenchymal Stem Cells

Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity

Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats.

Cardiac senescence is alleviated by the natural flavone acacetin via enhancing mitophagy

Exercise training restores IGFIR survival signaling in d-galactose induced-aging rats to suppress cardiac apoptosis

Effect of Aging on Related Biological Activity Factors in Gastric Fundic Mucosa in Beagle Dogs

Glucagon-Like Peptide-2 Ameliorates Age-Associated Bone Loss and Gut Barrier Dysfunction in Senescence-Accelerated Mouse Prone 6 Mice

Cell therapy rescues aging-induced beta-1 adrenergic receptor and GRK2 dysfunction in the coronary microcirculation